Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1995 2
1997 23
1998 93
1999 137
2000 119
2001 109
2002 133
2003 120
2004 119
2005 132
2006 153
2007 166
2008 163
2009 137
2010 137
2011 133
2012 176
2013 185
2014 175
2015 145
2016 129
2017 106
2018 88
2019 54
2020 3
Text availability
Article attribute
Article type
Publication date

Search Results

2,590 results
Results by year
Filters applied: . Clear all
Page 1
Environmental, genetic and epigenetic contributions to cocaine addiction.
Pierce RC, Fant B, Swinford-Jackson SE, Heller EA, Berrettini WH, Wimmer ME. Pierce RC, et al. Neuropsychopharmacology. 2018 Jun;43(7):1471-1480. doi: 10.1038/s41386-018-0008-x. Epub 2018 Feb 5. Neuropsychopharmacology. 2018. PMID: 29453446 Free PMC article. Review.
Topiramate in the treatment of cocaine use disorder.
Prince V, Bowling KC. Prince V, et al. Am J Health Syst Pharm. 2018 Jan 1;75(1):e13-e22. doi: 10.2146/ajhp160542. Am J Health Syst Pharm. 2018. PMID: 29273608 Review.
[Cocaine - Characteristics and addiction].
Girczys-Połedniok K, Pudlo R, Jarząb M, Szymlak A. Girczys-Połedniok K, et al. Med Pr. 2016;67(4):537-44. doi: 10.13075/mp.5893.00291. Med Pr. 2016. PMID: 27623834 Free article. Review. Polish.
Anticonvulsants for cocaine dependence.
Minozzi S, Cinquini M, Amato L, Davoli M, Farrell MF, Pani PP, Vecchi S. Minozzi S, et al. Cochrane Database Syst Rev. 2015 Apr 17;(4):CD006754. doi: 10.1002/14651858.CD006754.pub4. Cochrane Database Syst Rev. 2015. PMID: 25882271 Review.
The efficacy of attention bias modification therapy in cocaine use disorders.
Mayer AR, Wilcox CE, Dodd AB, Klimaj SD, Dekonenko CJ, Claus ED, Bogenschutz M. Mayer AR, et al. Am J Drug Alcohol Abuse. 2016 Jul;42(4):459-68. doi: 10.3109/00952990.2016.1151523. Epub 2016 May 16. Am J Drug Alcohol Abuse. 2016. PMID: 27184297 Free PMC article. Clinical Trial.
[AWMF-guideline: cocaine-, amphetamine-, ecstasy- and hallucinogen-related disorders].
Thomasius R, Gouzoulis-Mayfrank E, Karus C, Wiedenmann H, Hermle L, Sack PM, Zeichner D, Küstner U, Schindler A, Krüger A, Uhlmann S, Petersen KU, Zapletalova P, Wartberg L, Schütz CG, Schulte-Markwort M, Obrocki J, Heinz A, Schmoldt A; Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaft. Thomasius R, et al. Fortschr Neurol Psychiatr. 2004 Dec;72(12):679-95. doi: 10.1055/s-2004-818531. Fortschr Neurol Psychiatr. 2004. PMID: 15580533 Review. German.
2,590 results
Jump to page
Feedback